Wordt geladen...
The clinical application of linagliptin in Asians
Asia has a growing diabetic population. Linagliptin, a member of dipeptidyl peptidase-4 inhibitor class, is unique in its nonlinear pharmacokinetics with the characteristics of rapid attainment of steady state, little accumulation, predominantly nonrenal route of elimination, prolonged terminal half...
Bewaard in:
| Gepubliceerd in: | Ther Clin Risk Manag |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4577268/ https://ncbi.nlm.nih.gov/pubmed/26396526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S64402 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|